Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
United States of America
COVID-19
Hepatitis B
2023
2022
Americas
Clear all
Type of publications
NITAG documentation
(14)
Systematic reviews (SYSVAC)
(8)
Topics
Available to download in languages
Regions
Americas
(22)
Countries
United States of America
(22)
Argentina
(3)
Canada
(20)
Chile
(5)
Uruguay
(1)
Diseases
COVID-19
(19)
Hepatitis B
(3)
Cholera
(3)
Ebola
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(7)
Influenza
(3)
Measles
(1)
Meningococcal disease
(1)
Mpox // Monkeypox
(1)
Mumps
(1)
Pneumococcal disease
(4)
Poliomyelitis
(1)
Rabies
(1)
RSV (Respiratory syncytial virus)
(2)
Rubella
(1)
Vaccine topics
Acceptance
(8)
Coverage
(1)
Efficacy/effectiveness
(2)
Ethical issues
(1)
Safety
(2)
Target population
Adolescents
(1)
Adults
(3)
All age groups
(4)
Children
(1)
Healthcare workers
(3)
Older adults
(1)
Pregnant women
(2)
Publication date
2023
(3)
2022
(19)
2021
(36)
2020
(49)
2019
(1)
2018
(2)
2011
(1)
2008
(1)
2006
(1)
2005
(1)
2000
(1)
22 results found
2022
∙
ACIP
ACIP Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines
2022
∙
ACIP
ACIP Update to the Evidence to Recommendations for a Pfizer-BioNTech COVID-19 Booster in Children Ages 5-11 Years
2022
CDC Clinical Considerations for Second COVID-19 Vaccine Booster Dose
2022
∙
Sara Oliver, ACIP
Evidence to recommendation Framework: mRNA COVID-19 vaccine in young children
2022
∙
ACIP
GRADE for Moderna COVID-19 Vaccine for Children Aged 6 Months–5 Years
2022
∙
ACIP
GRADE for Pfizer-BioNTech COVID-19 Vaccine for Children Aged 6 Months–4 Years
2022
∙
Elisha Hall, ACIP
Interim Clinical Considerations Update for Pediatric COVID-19 Vaccines
2022
∙
ACIP
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years
2022
∙
ACIP, Kevin Chatham-Stephens
Pediatric COVID-19 Vaccine Planning for Children 6 Months–4 Years
2022
∙
ACIP
Safety & Immunogenicity of a 3-Antigen Hepatitis B Vaccine, PreHevbrio™
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register